BD (Becton, Dickinson and Company) announced on October 30, 2024, the launch of its new BD® Intraosseous Vascular Access System, designed for rapid delivery of fluids or medication in critical emergency situations. This system provides quick access to the circulatory system when traditional intravenous access is challenging or delayed.
The BD® IO System is the only intraosseous device on the market that can be placed after the extension set is attached and features integrated passive needle tip safety, protecting care providers from needlestick injuries. Clinicians can select from five needle lengths to accommodate a broad range of adult and pediatric patients.
A key differentiator is the powered driver's rechargeable battery, which extends its life up to 12 times compared to non-rechargeable competitive drills. This innovation aims to support medical teams in delivering high-quality access and improving patient outcomes during life-saving emergency health situations.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.